|
HMBOX1
|
homeobox containing 1 |
|
|
|
|
HSD17B13
|
hydroxysteroid 17-beta dehydrogenase 13 |
- Lipid particle organization
|
|
|
|
KRTAP3-1
|
keratin associated protein 3-1 |
|
|
|
|
LEPROTL1
|
leptin receptor overlapping transcript like 1 |
|
|
|
|
LITAF
|
lipopolysaccharide induced TNF factor |
|
|
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
|
|
LMNA
|
lamin A/C |
- XBP1(S) activates chaperone genes
- Signaling by BRAF and RAF1 fusions
|
|
- Mandibuloacral dysplasia
- Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
- Emery-Dreifuss muscular dystrophy
- Dilated cardiomyopathy (DCM)
- Limb-girdle muscular dystrophy (LGMD)
- Hutchinson-Gilford progeria syndrome
- Restrictive dermopathy
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
- Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
|
|
LNX1
|
ligand of numb-protein X 1 |
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
MIEF2
|
mitochondrial elongation factor 2 |
|
|
|
|
NDRG4
|
NDRG family member 4 |
|
|
|
|
NTAQ1
|
N-terminal glutamine amidase 1 |
|
|
|
|
PICK1
|
protein interacting with PRKCA 1 |
- Cell surface interactions at the vascular wall
- Trafficking of GluR2-containing AMPA receptors
|
|
|
|
PTPN9
|
protein tyrosine phosphatase non-receptor type 9 |
|
|
|
|
RPS20
|
ribosomal protein S20 |
- L13a-mediated translational silencing of Ceruloplasmin expression
- Peptide chain elongation
- SRP-dependent cotranslational protein targeting to membrane
- SRP-dependent cotranslational protein targeting to membrane
- Viral mRNA Translation
- Selenocysteine synthesis
- Major pathway of rRNA processing in the nucleolus and cytosol
- Translation initiation complex formation
- Formation of a pool of free 40S subunits
- Formation of the ternary complex, and subsequently, the 43S complex
- Ribosomal scanning and start codon recognition
- GTP hydrolysis and joining of the 60S ribosomal subunit
- Eukaryotic Translation Termination
- Regulation of expression of SLITs and ROBOs
- Response of EIF2AK4 (GCN2) to amino acid deficiency
- SARS-CoV-1 modulates host translation machinery
- SARS-CoV-2 modulates host translation machinery
- Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
- Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
- PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA
- ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA
|
|
|
|
SDCBP
|
syndecan binding protein |
- Ephrin signaling
- Neurofascin interactions
- RIPK1-mediated regulated necrosis
- Regulation of necroptotic cell death
- Neutrophil degranulation
|
|
|
|
SLC30A8
|
solute carrier family 30 member 8 |
- Insulin processing
- Zinc efflux and compartmentalization by the SLC30 family
|
|
- Type II diabetes mellitus
|
|
SNX1
|
sorting nexin 1 |
|
|
|
|
SNX11
|
sorting nexin 11 |
|
|
|
|
SNX15
|
sorting nexin 15 |
|
|
|
|
SNX8
|
sorting nexin 8 |
|
|
|
|
SPG21
|
SPG21 abhydrolase domain containing, maspardin |
|
|
- Hereditary spastic paraplegia (SPG)
|